JP2010043078A - アゴメラチン合成の新規な方法 - Google Patents
アゴメラチン合成の新規な方法 Download PDFInfo
- Publication number
- JP2010043078A JP2010043078A JP2009182087A JP2009182087A JP2010043078A JP 2010043078 A JP2010043078 A JP 2010043078A JP 2009182087 A JP2009182087 A JP 2009182087A JP 2009182087 A JP2009182087 A JP 2009182087A JP 2010043078 A JP2010043078 A JP 2010043078A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- agomelatine
- synthesis
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- IETMWQRDUVRIBX-ONNFQVAWSA-N C/C=C(/C(C(N)=O)=O)\c1cc(OC)ccc1C Chemical compound C/C=C(/C(C(N)=O)=O)\c1cc(OC)ccc1C IETMWQRDUVRIBX-ONNFQVAWSA-N 0.000 description 1
- 0 COc1cc2c(CC*)cccc2cc1 Chemical compound COc1cc2c(CC*)cccc2cc1 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/02—Preparation of carboxylic acid amides from carboxylic acids or from esters, anhydrides, or halides thereof by reaction with ammonia or amines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/08—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of a saturated carbon skeleton containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/70—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/72—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms
- C07C235/76—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton
- C07C235/78—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton the carbon skeleton containing rings
Abstract
Description
式(I)で示される化合物を、工業的規模で、簡単で安価な出発原料より優れた収率で得ることを可能にする;
出発物質中にナフタレン環系が存在しているため、芳香族化反応を避けることが可能である;
最後に、得られた式(I)で示される化合物は、特許明細書EP1564202に記載されている結晶形の性質を、再現性良く有している。
工程A:(7−メトキシ−1−ナフチル)(オキソ)酢酸
反応器中、18−クラウン−6−エーテル4mgを、そして次にNaNH2230mgを、続けてDMSO 1ml中の3−メトキシアセナフトキノン100mgの懸濁液中に導入した。混合物を周囲温度で30分間撹拌した。次に、水(2ml)を加え、続けて2N HCl溶液(3ml)を加えた。酢酸エチルにより2回抽出した後、溶媒をNa2SO4で乾燥させ、そして次に蒸発させて標記生成物を黄色の固体として88%の収率及び94%以上の高い化学純度で得た。
融点:99℃
反応器中、周囲温度において、工程Aで得た化合物1gをアセトニトリル30ml中に導入し、そして次にプロピルホスホン酸無水物4.39gとNH4Cl 438mgを加え、そして添加の終わりに、ジイソプロピルアミン3.8mlを加えた。溶液を窒素雰囲気下で4時間撹拌し、溶媒を蒸発させ、残渣を飽和NaCl水溶液にとり、そして酢酸エチルによる抽出を実施した。溶媒をNa2SO4で乾燥させ、そして次に蒸発させて、標記生成物を橙色の固体として80%の収率及び90%の化学純度で得た。
融点:112℃
THF(20ml)に溶解した工程Bで得た化合物480mgを、反応器中に導入し、続けて2当量のAlCl3を導入し、そして最後に、6当量のBH3.THF溶液をゆっくりと導入し、そして反応混合物を2.5時間撹拌した。次に水(12ml)を加え、続けて1N水酸化ナトリウム溶液25mlと一緒に固体水酸化ナトリウム800mgを加え、そしてメチルtert−ブチルエーテル(20ml)により3回抽出を実施した。次に溶媒をNa2SO4で乾燥させ、そして次に蒸発させて、標記生成物を黄色の油状物として80%の収率及び95%の化学純度で得た。
反応器中、工程Cで得た化合物5gと、酢酸ナトリウム2gをエタノール中に導入した。混合物を撹拌し、次に無水酢酸2.3gを加え、反応混合物を還流まで加熱し、そして水20mlを加えた。反応混合物を周囲温度に戻るまで放冷し、得られた沈殿物を濾過し、エタノール/水の35/65混合物で洗浄して、標記生成物を80%の収率及び99%の化学純度で得た。
融点:108℃
Bruker AXSからのD8高分解能回折計を用い、次のパラメータを用いてデータの記録を実施した:2θに関して角度範囲3°〜90°、0.01°のステップ及び1ステップ当たり30秒。実施例1で得たN−[2−(7−メトキシ−1−ナフチル)エチル]アセトアミドの粉末を、透過マウント支持体に置いた。X線源は、銅菅(λCuKα1=1.54056Å)である。マウントは、前方のモノクロメータ(Ge(III)結晶)とエネルギー分解固体検出器(MXP−D1、Moxtec−SEPH)を含む。化合物は、十分に結晶化されている:線の半値幅は、2θに関して0.07°程度であった。
このようにして、次のパラメータを決定した:
−単位格子の結晶構造:単斜晶系
−単位格子パラメータ:a=20.0903Å、b=9.3194Å、c=15.4796Å、β=108.667°
−空間群:P21/n
−単位格子中の分子数:8
−単位格子の体積:Vunit cell=2746.742Å3
−密度:d=1.13g/cm3
実施例1で得た化合物の結晶形は、Siemens D5005回折計(銅対陰極)を用いて測定した次のX線粉末回折図により特徴付けられ、面間距離d、ブラッグ角度2シータ、及び相対強度(最も強い線に対する百分率として表示)により表示した。
Claims (10)
- 式(II)で示される化合物の式(III)で示される化合物への変換が、NaNH2を用いて実施される、請求項1記載の式(I)で示される化合物の合成方法。
- 式(IV)で示される化合物の式(V)で示される化合物への変換が、BH3.THF/AlCl3の組み合わせを用いて実施される、請求項1記載の式(I)で示される化合物の合成方法。
- アゴメラチンの合成における中間体として使用される、請求項1記載の式(IV)で示される化合物。
- アゴメラチンの合成における、請求項4記載の式(IV)で示される化合物の使用。
- アゴメラチンの合成における、請求項1記載の式(II)で示される化合物の使用。
- アゴメラチンの合成における、請求項1記載の式(III)で示される化合物の使用。
- 式(III)で示される化合物から出発する、請求項1記載のアゴメラチンの合成方法であって、式(III)で示される化合物が、請求項1又は2のいずれか一項記載の合成方法により得られる方法。
- 式(IV)で示される化合物から出発する、請求項1記載のアゴメラチンの合成方法であって、式(IV)で示される化合物が、請求項1又は2のいずれか一項記載の合成方法により得られる方法。
- 式(V)で示される化合物から出発する、請求項1記載のアゴメラチンの合成方法であって、式(V)で示される化合物が、請求項1〜3のいずれか一項記載の合成方法により得られる方法。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0804464A FR2934855B1 (fr) | 2008-08-05 | 2008-08-05 | Nouveau procede de synthese de l'agomelatine |
FR08/04464 | 2008-08-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010043078A true JP2010043078A (ja) | 2010-02-25 |
JP5021004B2 JP5021004B2 (ja) | 2012-09-05 |
Family
ID=40409856
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009182087A Expired - Fee Related JP5021004B2 (ja) | 2008-08-05 | 2009-08-05 | アゴメラチン合成の新規な方法 |
Country Status (46)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9151198B2 (en) | 2011-03-03 | 2015-10-06 | Tenneco Automotive Operating Company Inc. | Poka-yoke mounting system for an exhaust treatment device |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2580183B1 (en) | 2010-06-10 | 2014-07-23 | Gador S.A. | New process for the preparation of n-[2-(7-methoxy-1-naphthyl)-ethyl]acetamide |
CN102531956B (zh) * | 2010-12-21 | 2014-07-09 | 浙江九洲药业股份有限公司 | 用于制备阿戈美拉汀的中间体及相关制备方法 |
EP2562151A1 (en) * | 2011-08-25 | 2013-02-27 | Dr. Reddy's Laboratories Ltd. | Processes for the preparation of agomelatine and its intermediates |
ITMI20121444A1 (it) | 2012-08-27 | 2014-02-28 | Procos Spa | Processo per la produzione di agomelatine |
FR3014437B1 (fr) * | 2013-12-05 | 2016-12-23 | Servier Lab | Nouveau procede de synthese de l'agomelatine |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0748331A (ja) * | 1990-02-27 | 1995-02-21 | Adir | ナフタレン構造を有する新しい誘導体、その製造方法およびそれを含む薬学的組成物 |
JPH093016A (ja) * | 1995-05-31 | 1997-01-07 | Adir | 新規アリール(アルキル)プロピルアミド、その製造方法及びそれを含有する医薬組成物 |
JP2005247844A (ja) * | 2004-02-13 | 2005-09-15 | Lab Servier | アゴメラチンの新規合成法及び新規結晶形ならびにそれを含有する医薬組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6037495A (en) * | 1994-09-06 | 2000-03-14 | Shinonogi & Co., Ltd. | Process for producing alkoxyiminoacetamide derivatives |
-
2008
- 2008-08-05 FR FR0804464A patent/FR2934855B1/fr not_active Expired - Fee Related
-
2009
- 2009-07-13 SG SG200904732-5A patent/SG158814A1/en unknown
- 2009-07-13 PE PE2009000938A patent/PE20100259A1/es not_active Application Discontinuation
- 2009-07-14 NZ NZ578381A patent/NZ578381A/en not_active IP Right Cessation
- 2009-07-14 UY UY0001031985A patent/UY31985A/es not_active Application Discontinuation
- 2009-07-14 MY MYPI20092953A patent/MY144746A/en unknown
- 2009-07-15 IL IL199875A patent/IL199875A/en not_active IP Right Cessation
- 2009-07-16 JO JO2009270A patent/JO2821B1/en active
- 2009-07-16 AU AU2009202905A patent/AU2009202905B2/en not_active Ceased
- 2009-07-16 CR CR10934A patent/CR10934A/es unknown
- 2009-07-20 ZA ZA200905051A patent/ZA200905051B/xx unknown
- 2009-07-21 AP AP2009004929A patent/AP2509A/xx active
- 2009-07-21 CN CN2009101514641A patent/CN101643431B/zh not_active Expired - Fee Related
- 2009-07-22 CL CL2009001632A patent/CL2009001632A1/es unknown
- 2009-07-24 CU CU20090131A patent/CU23858B1/es active IP Right Grant
- 2009-07-27 MX MX2009007971A patent/MX2009007971A/es active IP Right Grant
- 2009-07-27 TW TW098125264A patent/TWI376365B/zh not_active IP Right Cessation
- 2009-07-29 SV SV2009003344A patent/SV2009003344A/es active IP Right Grant
- 2009-07-30 NI NI200900152A patent/NI200900152A/es unknown
- 2009-07-31 GT GT200900218A patent/GT200900218A/es unknown
- 2009-07-31 EC EC2009009549A patent/ECSP099549A/es unknown
- 2009-07-31 MA MA32132A patent/MA31830B1/fr unknown
- 2009-08-02 SA SA109300498A patent/SA109300498B1/ar unknown
- 2009-08-03 CA CA2674764A patent/CA2674764C/fr not_active Expired - Fee Related
- 2009-08-03 US US12/462,360 patent/US8143449B2/en not_active Expired - Fee Related
- 2009-08-03 AR ARP090102968A patent/AR074887A1/es unknown
- 2009-08-03 GE GEAP200911400A patent/GEP20115344B/en unknown
- 2009-08-03 KR KR1020090071243A patent/KR101127357B1/ko active IP Right Grant
- 2009-08-04 RS RS20110293A patent/RS51740B/en unknown
- 2009-08-04 SI SI200930047T patent/SI2151429T1/sl unknown
- 2009-08-04 DK DK09290607.2T patent/DK2151429T3/da active
- 2009-08-04 BR BRPI0903045-0A patent/BRPI0903045A2/pt not_active IP Right Cessation
- 2009-08-04 HN HN2009001435A patent/HN2009001435A/es unknown
- 2009-08-04 ME MEP-2009-256A patent/ME00927B/me unknown
- 2009-08-04 UA UAA200908225A patent/UA106195C2/ru unknown
- 2009-08-04 WO PCT/FR2009/000973 patent/WO2010015746A1/fr active Application Filing
- 2009-08-04 PL PL09290607T patent/PL2151429T3/pl unknown
- 2009-08-04 AT AT09290607T patent/ATE510816T1/de active
- 2009-08-04 ES ES09290607T patent/ES2367236T3/es active Active
- 2009-08-04 EA EA200900943A patent/EA017684B1/ru not_active IP Right Cessation
- 2009-08-04 EP EP09290607A patent/EP2151429B1/fr active Active
- 2009-08-04 PT PT09290607T patent/PT2151429E/pt unknown
- 2009-08-05 JP JP2009182087A patent/JP5021004B2/ja not_active Expired - Fee Related
-
2010
- 2010-08-09 HK HK10107579.2A patent/HK1141004A1/xx not_active IP Right Cessation
-
2011
- 2011-06-20 CY CY20111100585T patent/CY1111573T1/el unknown
- 2011-08-01 HR HR20110568T patent/HRP20110568T1/xx unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0748331A (ja) * | 1990-02-27 | 1995-02-21 | Adir | ナフタレン構造を有する新しい誘導体、その製造方法およびそれを含む薬学的組成物 |
JPH093016A (ja) * | 1995-05-31 | 1997-01-07 | Adir | 新規アリール(アルキル)プロピルアミド、その製造方法及びそれを含有する医薬組成物 |
JP2005247844A (ja) * | 2004-02-13 | 2005-09-15 | Lab Servier | アゴメラチンの新規合成法及び新規結晶形ならびにそれを含有する医薬組成物 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9151198B2 (en) | 2011-03-03 | 2015-10-06 | Tenneco Automotive Operating Company Inc. | Poka-yoke mounting system for an exhaust treatment device |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5112399B2 (ja) | アゴメラチン合成の新規な方法 | |
KR101127278B1 (ko) | 아고멜라틴의 합성 방법 | |
JP5021004B2 (ja) | アゴメラチン合成の新規な方法 | |
JP2005247844A (ja) | アゴメラチンの新規合成法及び新規結晶形ならびにそれを含有する医薬組成物 | |
KR100682698B1 (ko) | (7메톡시1나프틸)아세토니트릴의 합성 방법 및 아고멜라틴의 합성에서의 이의 용도 | |
TWI438180B (zh) | 阿戈美拉丁(agomelatine)之新穎合成方法 | |
KR20170018799A (ko) | 신규한 7-메톡시-나프탈렌-1-카발데하이드의 합성 방법 및 아고멜라틴의 합성에서의 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20120509 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20120522 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20120613 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 Ref document number: 5021004 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150622 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |